Investor profile
Sam Glazer
Private equity, Venture debt & Senior Associate, Research & Investments at Royalty Pharma
Sam Glazer is a Senior Associate, Research & Investments at Royalty Pharma, whose known portfolio counts 10 companies.
Is Sam Glazer a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Senior Associate, Research & Investments at Royalty Pharma, whose known portfolio counts 10 companies
- Zenas BioPharma
- Zymeworks
- Revolution Medicines
- Elektrofi
- Kailera Therapeutics
- Syndax Pharmaceuticals
- Cytokinetics
- Denali Therapeutics
- Teva Pharmaceuticals
- Ascendis Pharma
Investor Profile
Founders in the listed sector Healthcare, and focus areas Biotech, Pharma and Pharma Royalties fall inside that listing.
Stage-wise, the deals at Royalty Pharma cluster around Growth, Late-Stage and Series B rounds.
The firm portfolio and the focus above give founders context on whether Sam Glazer matches their raise.
Colleagues at Royalty Pharma
Pablo Legorreta
Founder & Chief Executive Officer
New York City, United States
Alim Ladha
Research and Investments
New York, United States
Kristen Overly
Research and Investments
New York, United States
Volodymyr Nikolenko
Investor
New York, United States
Frequently asked questions
Who is Sam Glazer?
Sam Glazer is a private equity investor and venture debt investor based in San Francisco, California, United States, listed as Senior Associate, Research & Investments at Royalty Pharma. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Sam Glazer personally.
What does Sam Glazer invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Pharma and Pharma Royalties. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Sam Glazer invest at?
Royalty Pharma appears in Growth, Late-Stage and Series B rounds across its known deals, and Sam Glazer is listed there as Senior Associate, Research & Investments. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Sam Glazer listed at?
Sam Glazer is listed as Senior Associate, Research & Investments at Royalty Pharma. 4 other people in the database share a firm with Sam Glazer.
How do I contact Sam Glazer?
A LinkedIn page is on file for Sam Glazer. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal